Javier Nuevo

1.3k total citations
59 papers, 776 citations indexed

About

Javier Nuevo is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Javier Nuevo has authored 59 papers receiving a total of 776 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Physiology, 23 papers in Pulmonary and Respiratory Medicine and 18 papers in Surgery. Recurrent topics in Javier Nuevo's work include Asthma and respiratory diseases (26 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (14 papers) and Respiratory and Cough-Related Research (13 papers). Javier Nuevo is often cited by papers focused on Asthma and respiratory diseases (26 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (14 papers) and Respiratory and Cough-Related Research (13 papers). Javier Nuevo collaborates with scholars based in Spain, United States and United Kingdom. Javier Nuevo's co-authors include Mónica Tafalla, Francisco Caamaño‐Isorna, Francisco Javier González‐Barcala, Ángel Lanas, Christer Janson, Andrew Menzies‐Gow, Maarten Boers, Alberto Papi, Jennifer K Quint and Cassandra Nan and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Javier Nuevo

49 papers receiving 755 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Javier Nuevo Spain 17 382 373 236 178 88 59 776
Christopher R. Daigle United States 19 232 0.6× 117 0.3× 777 3.3× 106 0.6× 53 0.6× 45 961
Yeongkeun Kwon South Korea 16 258 0.7× 134 0.4× 338 1.4× 35 0.2× 28 0.3× 54 658
Sulabha Ramachandran United States 16 585 1.5× 599 1.6× 41 0.2× 7 0.0× 30 0.3× 30 984
Alexander W. Phillips United Kingdom 19 133 0.3× 541 1.5× 814 3.4× 87 0.5× 15 0.2× 101 1.1k
C. Bonardi Italy 11 480 1.3× 52 0.1× 171 0.7× 13 0.1× 52 0.6× 15 723
Akshay Roy-Chaudhury United States 4 173 0.5× 135 0.4× 79 0.3× 5 0.0× 162 1.8× 5 576
My Engström Sweden 14 343 0.9× 65 0.2× 708 3.0× 58 0.3× 10 0.1× 50 921
Joseph D. Cappuccio United States 8 49 0.1× 569 1.5× 233 1.0× 20 0.1× 97 1.1× 9 865
Alexander Arynchyn United States 11 148 0.4× 175 0.5× 66 0.3× 4 0.0× 23 0.3× 15 768
Yu‐Wen Wen Taiwan 16 99 0.3× 326 0.9× 332 1.4× 12 0.1× 31 0.4× 48 770

Countries citing papers authored by Javier Nuevo

Since Specialization
Citations

This map shows the geographic impact of Javier Nuevo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Javier Nuevo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Javier Nuevo more than expected).

Fields of papers citing papers by Javier Nuevo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Javier Nuevo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Javier Nuevo. The network helps show where Javier Nuevo may publish in the future.

Co-authorship network of co-authors of Javier Nuevo

This figure shows the co-authorship network connecting the top 25 collaborators of Javier Nuevo. A scholar is included among the top collaborators of Javier Nuevo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Javier Nuevo. Javier Nuevo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jackson, David J., Parameswaran Nair, Benjamin Emmanuel, et al.. (2025). XALOC-1. CHEST Journal. 168(1). 19–32. 3 indexed citations
2.
Jackson, David J., Girolamo Pelaia, Benjamin Emmanuel, et al.. (2024). Benralizumab in severe eosinophilic asthma by previous biologic use and key clinical subgroups: real-world XALOC-1 programme. European Respiratory Journal. 64(1). 2301521–2301521. 28 indexed citations
3.
Molina, Jesús, et al.. (2023). Clinical Consequences of the Overuse of Short-Acting β2-Adrenergic Agonists (SABA) in the Treatment of Asthma in Spain: The SABINA Study. SHILAP Revista de lepidopterología. 5(2). 100232–100232. 3 indexed citations
4.
Soler‐Cataluña, Juan José, et al.. (2023). Impact of COPD Exacerbations and Burden of Disease in Spain: AVOIDEX Study. International Journal of COPD. Volume 18. 1103–1114. 11 indexed citations
5.
Muñoz, Xavier, et al.. (2022). Clinical burden related to oral corticosteroid treatment of severe asthma in Spain: LEVANTE study. Journal of Asthma. 60(5). 890–899. 2 indexed citations
6.
Reddel, Helen K., Jørgen Vestbo, Àlvar Agustí, et al.. (2021). Heterogeneity within and between physician-diagnosed asthma and/or COPD: NOVELTY cohort. European Respiratory Journal. 58(3). 2003927–2003927. 44 indexed citations
7.
Janson, Christer, Andrew Menzies‐Gow, Cassandra Nan, et al.. (2020). SABINA: An Overview of Short-Acting β2-Agonist Use in Asthma in European Countries. Advances in Therapy. 37(3). 1124–1135. 93 indexed citations
8.
Rebordosa, Cristina, Jaume Aguado, Estel Plana, et al.. (2019). Use of aclidinium did not increase the risk of death in a noninterventional cohort study in the Clinical Practice Research Datalink (CPRD), United Kingdom. Respiratory Medicine. 152. 37–43. 4 indexed citations
9.
Small, Mark, et al.. (2018). The impacts of morning, daytime, and nighttime symptoms on disease burden in real-world patients with COPD. International Journal of COPD. Volume 13. 1557–1568. 8 indexed citations
10.
Kerkhof, Marjan, Trung N. Tran, Maarten van den Berge, et al.. (2018). Association between blood eosinophil count and risk of readmission for patients with asthma: Historical cohort study. PLoS ONE. 13(7). e0201143–e0201143. 30 indexed citations
11.
Capel, Margarita, et al.. (2018). PRS70 - REAL-LIFE RETROSPECTIVE OBSERVATIONAL STUDY TO DETERMINE THE PREVALENCE AND ECONOMIC BURDEN OF SEVERE ASTHMA. Value in Health. 21. S416–S416. 2 indexed citations
12.
Borghi, Claudio, Fernando Rodríguez‐Artalejo, Guy De Backer, et al.. (2018). Serum uric acid levels are associated with cardiovascular risk score: A post hoc analysis of the EURIKA study. International Journal of Cardiology. 253. 167–173. 40 indexed citations
13.
Morlock, Robert, Pierre Chevalier, Laura Horne, et al.. (2016). Disease Control, Health Resource Use, Healthcare Costs, and Predictors in Gout Patients in the United States, the United Kingdom, Germany, and France: A Retrospective Analysis. Rheumatology and Therapy. 3(1). 53–75. 5 indexed citations
14.
Lanas, Ángel, Maarten Boers, & Javier Nuevo. (2013). Gastrointestinal events in at-risk patients starting non-steroidal anti-inflammatory drugs (NSAIDs) for rheumatic diseases: the EVIDENCE study of European routine practice. Annals of the Rheumatic Diseases. 74(4). 675–681. 40 indexed citations
15.
Ponce, Julio, Vicente Garrigues, Lars Agréus, et al.. (2012). Structured management strategy based on the Gastro‐oesophageal Reflux Disease (GERD) Questionnaire (GerdQ) vs. usual primary care for GERD: pooled analysis of five cluster‐randomised European studies. International Journal of Clinical Practice. 66(9). 897–905. 13 indexed citations
16.
González‐Barcala, Francisco Javier, et al.. (2012). Factors associated with health-related quality of life in adults with asthma. A cross-sectional study. Multidisciplinary Respiratory Medicine. 7(1). 32–32. 61 indexed citations
17.
Nuevo, Javier, et al.. (2011). Sesgos de confusión por indicación y gravedad en estudios observacionales. Gaceta Sanitaria. 25(2). 170–172. 2 indexed citations
18.
González‐Barcala, Francisco Javier, et al.. (2010). Factors Associated with a Higher Prevalence of Work Disability among Asthmatic Patients. Journal of Asthma. 48(2). 194–199. 27 indexed citations
19.
Tafalla, Mónica, Javier Nuevo, Javier Zapardiel, & Javier P. Gisbert. (2010). Estudio de síntomas relevantes y atención clínica en la enfermedad por reflujo gastroesofágico en atención primaria en España. Gastroenterología y Hepatología. 33(7). 490–497.
20.
Nuevo, Javier, Mónica Tafalla, & Javier Zapardiel. (2009). Validación del Cuestionario sobre Alteraciones de Reflujo (RDQ) y de la Escala de Impacto de la Enfermedad por Reflujo Gastroesofágico (GIS) para población española. Gastroenterología y Hepatología. 32(4). 264–273. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christopher R. Daigle Breakdown of academic impact, for papers by Yeongkeun Kwon Breakdown of academic impact, for papers by Sulabha Ramachandran Breakdown of academic impact, for papers by Alexander W. Phillips Breakdown of academic impact, for papers by C. Bonardi Breakdown of academic impact, for papers by Akshay Roy-Chaudhury Breakdown of academic impact, for papers by My Engström Breakdown of academic impact, for papers by Joseph D. Cappuccio Breakdown of academic impact, for papers by Alexander Arynchyn Breakdown of academic impact, for papers by Yu‐Wen Wen
Rankless by CCL
2026